ANL 29.68 Increased By ▲ 1.38 (4.88%)
ASC 20.22 Decreased By ▼ -0.03 (-0.15%)
ASL 24.98 Decreased By ▼ -0.12 (-0.48%)
BOP 8.28 Increased By ▲ 0.03 (0.36%)
BYCO 10.31 Increased By ▲ 0.17 (1.68%)
FCCL 22.20 Increased By ▲ 0.28 (1.28%)
FFBL 26.70 Decreased By ▼ -0.05 (-0.19%)
FFL 20.25 Increased By ▲ 0.15 (0.75%)
FNEL 9.03 Increased By ▲ 0.09 (1.01%)
GGGL 27.40 Increased By ▲ 1.15 (4.38%)
GGL 45.63 Increased By ▲ 3.01 (7.06%)
HUMNL 7.28 Increased By ▲ 0.08 (1.11%)
JSCL 21.85 Increased By ▲ 0.45 (2.1%)
KAPCO 39.60 Increased By ▲ 0.41 (1.05%)
KEL 3.91 Increased By ▲ 0.05 (1.3%)
MDTL 3.64 Increased By ▲ 0.10 (2.82%)
MLCF 45.54 Increased By ▲ 1.54 (3.5%)
NETSOL 161.80 Increased By ▲ 3.29 (2.08%)
PACE 7.45 Increased By ▲ 0.25 (3.47%)
PAEL 33.30 Increased By ▲ 0.50 (1.52%)
PIBTL 11.15 Increased By ▲ 0.11 (1%)
POWER 9.20 Increased By ▲ 0.09 (0.99%)
PRL 23.90 Increased By ▲ 0.95 (4.14%)
PTC 12.12 Increased By ▲ 0.29 (2.45%)
SILK 1.79 Increased By ▲ 0.03 (1.7%)
SNGP 50.60 Increased By ▲ 1.10 (2.22%)
TELE 17.04 Increased By ▲ 1.24 (7.85%)
TRG 162.50 Increased By ▲ 4.30 (2.72%)
UNITY 40.80 Increased By ▲ 0.80 (2%)
WTL 3.67 Increased By ▲ 0.15 (4.26%)
BR100 5,189 Increased By ▲ 64.21 (1.25%)
BR30 26,249 Increased By ▲ 598.06 (2.33%)
KSE100 47,758 Increased By ▲ 305.07 (0.64%)
KSE30 19,110 Increased By ▲ 124.84 (0.66%)

Coronavirus
VERY HIGH Source: covid.gov.pk
Pakistan Deaths
23,575
4624hr
Pakistan Cases
1,047,999
4,72224hr
8.15% positivity
Sindh
389,699
Punjab
359,321
Balochistan
30,749
Islamabad
88,676
KPK
145,862

MOSCOW: The developer of Russia’s Sputnik V coronavirus vaccine said Wednesday its jab did not cause blood clots, a potential side effect that has disrupted rollouts in several Western countries.

The United States has recommended pausing its rollout of the Johnson & Johnson vaccine after one person out of nearly seven million Americans died from a rare type of clot in the brain following inoculation .

Denmark on Wednesday became the first country in Europe to suspend use of the AstraZeneca jab after reports of rare but serious cases of blood clots among those that had received the vaccine.

Like the Johnson & Johnson and AstraZeneca vaccines, Russia’s Sputnik V jab uses adapted strains of the adenovirus that causes the common cold.

On Wednesday, the state-run Gamaleya research institute, which developed Sputnik V vaccine, said there was no risk of blot clots from its jab.

“A comprehensive analysis of adverse events during clinical trials and over the course of mass vaccinations with the Sputnik V vaccine showed that there were no cases of cerebral venous sinus thrombosis,” it said in a statement.

Russia’s registration of Sputnik in August last year triggered criticism both at home and abroad over the fast-track procedure, but a leading medical journal said this year it was safe and highly effective.

The vaccine has been registered for use in dozens of countries.

The Gamaleya institute said it was “ready to share its purification technology with other vaccine producers in order to help them minimise the risk of adverse effects during vaccination.”

President Vladimir Putin said Wednesday he had received the second dose of a vaccine against the coronavirus and encouraged Russians to follow his example.